Skip to Content
Merck

Beclomethasone dipropionate in the management of rhinitis--a review.

Annals of allergy (1982-09-01)
P Small, M Black, S Frenkiel, G N Wachs
ABSTRACT

Beclomethasone dipropionate has been demonstrated to be effective in the treatment of seasonal and perennial rhinitis. Comparative studies with other medications are lacking. Adverse reactions are frequent but minor. No alterations of the hypothalamic-pituitary-adrenal axis, nasal mucosal histology or bacterial and fungal flora have been recognized.

MATERIALS
Product Number
Brand
Product Description

Beclometasone dipropionate for system suitability, European Pharmacopoeia (EP) Reference Standard
Supelco
Beclomethasone dipropionate, analytical standard, for drug analysis
USP
Beclomethasone dipropionate, United States Pharmacopeia (USP) Reference Standard
Beclometasone dipropionate for peak identification, European Pharmacopoeia (EP) Reference Standard
Beclomethasone dipropionate, anhydrous, European Pharmacopoeia (EP) Reference Standard